NSDVX
Price
$22.31
Change
-$0.90 (-3.88%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

NSDVX vs VSIAX

Header iconNSDVX vs VSIAX Comparison
Open Charts NSDVX vs VSIAXBanner chart's image
North Star Dividend I
Price$22.31
Change-$0.90 (-3.88%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
NSDVX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NSDVX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSDVX is a Buy and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. NSDVX (94.5M). VSIAX pays higher dividends than NSDVX: VSIAX (2.01) vs NSDVX (1.73). NSDVX was incepted earlier than VSIAX: NSDVX (12 years) vs VSIAX (13 years). NSDVX is a more actively managed with annual turnover of: 23.00 vs. VSIAX (16.00). VSIAX has a lower initial minimum investment than NSDVX: VSIAX (3000) vs NSDVX (5000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. NSDVX (9.95). VSIAX return over 5 years is better than : 52.83 vs. NSDVX (28.31).
NSDVXVSIAXNSDVX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years13 years-
Gain YTD8.77215.03158%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets94.5M63B0%
Annual Yield % from dividends1.732.0186%
Returns for 1 year9.9516.2361%
Returns for 3 years9.5820.6746%
Returns for 5 years28.3152.8354%
Returns for 10 years51.97105.6549%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics